NewsBot
06-27-2009, 09:30 AM
Reuters - Sanofi-Aventis's diabetes drug Lantus may increase the risk of cancer, according to European studies involving some 300,000 insulin-treated patients, prompting a call from experts for more research.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/nm/20090627/hl_nm/us_sanofi_lantus)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/nm/20090627/hl_nm/us_sanofi_lantus)
(From Yahoo Diseases)